MOVING SCIENCE FORWARD
MultiPark is a strategic research area funded by the Swedish Government. The aim of the MultiPark project is to radically improve life for patients suffering from Parkinson’s disease. In a multidisciplinary mobilization neuroscientists are cooperating with researchers from nanotechnology, chemistry, physics and computer science. A union between experimental and clinical science is at the core of the overarching MultiPark vision – improving the quality of life for Parkinson patients.
Once a diplomat frequenting war-torn corners of the world, France’s ambassador to Sweden now has quite a different set of challenges to meet. For example, integrating into Swedish social culture by navigating the do’s and don'ts of Friday fika. But Pierre LaCroix, a man with many strings to his bow, is also concerned with promoting French-Swedish scientific collaboration. On February 17th he visited MultiPark to get further insight into the neuroscientific research going on within the BMC walls.
The Patient Participation in Parkinson's event on February 4th brought together strong voices in the growing debate on the role of patients as partners in health care development. Two prominent patient advocates, Sara Riggare and Jon Stamford, were joined on stage by Marjan Faber of the Dutch organization ParkinsonNet and Peter Hagell, an expert in the field of patient-driven outcomes measurements. The concluding debate, live webcast online, triggered a broader discussion where engaged contributors took part via twitter and other social media.
With his recent SRC grant of 2,3 M SEK MultiPark ethnologist Markus Idvall is shifting his attention further towards Parkinson’s disease. In the project ‘The Two Horizons of Research’, kicking off in 2014, he will investigate the cultural and social negotiation that is taking place between researchers and patients when clinical trials are performed.